Companion diagnostics are tests that help identify patients for targeted therapy. In the context of cancer treatment, companion diagnostics are often used to identify specific genetic mutations or biomarkers that are present in a patient's tumor. Identifying these mutations or markers can help physicians tailor treatment regimens to the specific needs of patients, thereby increasing the likelihood of a positive response to therapy and improving overall outcomes. Tumor companion diagnostics are now playing an increasingly important role in guiding targeted therapies, suggesting mechanisms of drug resistance, guiding immunotherapy, and unlocking new drug development paradigms.
CD Genomics offers specialized tumor companion diagnostic reference products to help you conduct targeted cancer therapy research and develop new drugs.
Our tumor companion diagnostic reference products are cell-derived controls that highly mimic patient samples, can be used as negative and positive controls for oncogene testing kits for small and large panels, as well as reference panels for pharmaceutical companies. The three main product formats are genomic DNA (gDNA), tumor circulating DNA (ctDNA), and FFPE.
Explore Our Tumor Companion Diagnostic Reference Products:
|Cat. No.||Product Name||Brief Description||Inquiry||Basket|
|TCDR001||CD Companion Diagnostic Reference||CD Companion Diagnostic Reference can meet the needs of negative and positive controls for kits, and corporate reference discs.|